Volume 16, Number 10—October 2010
Research
Effectiveness of Personal Protective Equipment and Oseltamivir Prophylaxis during Avian Influenza A (H7N7) Epidemic, the Netherlands, 2003
Dennis E. te Beest
, Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. Koopmans
, Michiel van Boven, Marian E.H. Bos, Arjan Stegeman, and Marion P.G. KoopmansTable 5
Comparison of conjunctivitis and serologic result case definitions for number of infections and prophylactic oseltamivir use during avian influenza A (H7N7) epidemic, the Netherlands, 2003*
| Oseltamivir use |
Conjunctivitis |
Serologic result |
|||
| Persons† |
Visits‡ |
Persons |
Visits |
||
| Not prescribed | 6/35 | 9/63 | 12/16 | 22/26 | |
| Prescribed but not used during visit | 12/45 | 25/80 | 26/34 | 48/64 | |
| Prescribed and used consistently | 7/54 | 9/113 | 24/41 | 54/85 | |
| Prescribed and used inconsistently | 5/26 | 13/65 | 11/18 | 24/39 | |
| Prescribed and consistency of use unknown | 4/9 | 8/23 | 4/7 | 11/18 | |
| Prescribed but period of use unknown | 9/47 | 15/109 | 17/30 | 40/68 | |
*Data resulted from a survey conducted among poultry workers after the epidemic.
†No. persons infected/total no. persons.
‡No. visits by infected persons/total no. visits. Because visits were classified into groups, persons may be in 2 categories (prescribed not used and prescribed used).
